The information contained in this section of Veloxis Pharmaceuticals A/S (the "Company") website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States of America (including its territories and possessions, any state of the United States and the District of Columbia, the "United States"), Canada, Australia and Japan, or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction, and does not constitute an offer to sell or the solicitation of an offer to buy or acquire, any ordinary shares or other securities of the Company in the United States, Canada, Australia, Japan or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

The shares of the Company referred to on this website (the "Shares") have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold within the United States absent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There is no intention to register any Shares referred to herein in the United States or to make a public offering of the Shares in the United States.

The Shares have also not been and will also not be registered under the applicable securities laws of Canada, Australia or Japan. There will be no public offer of the Shares in Canada, Australia or Japan.

Access to the information and documents contained on the following websites may be illegal in certain jurisdictions, and only certain categories of persons may be authorized to access such information and documents. All persons who wish to have access to the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. The Company assumes no responsibility if there is a violation of applicable law and regulations by any person.

I therefore certify that:

1. I am resident and physically present outside the United States, Canada, Australia and Japan;

2. I am resident and physically present outside the United States, Canada, Australia and Japan and, in that case, I am authorized to access the information and documents on this website without being subject to any legal restriction and without any further action required by the Company;

3. I have read, understand and agree to comply with all of the restrictions set forth above.

Access to this information is limited to authorized persons who are resident and physically present in other jurisdictions outside the United States, Canada, Australia and Japan.

The information contained in this section of Veloxis Pharmaceuticals A/S’ website is restricted and is not for release, publication or distribution, directly or indirectly, in whole or in part in, into or from the United States of America (including its territories and possessions), any state of the United States and the District of Columbia, Canada, Australia and Japan or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.